Robert Burlingame

Robert Burlingame appears in our data through filings on Sonoma Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 30 January 2007 and the latest from 16 June 2009.

The open-market record is one-sided, with 2 purchases worth €668k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2009: 2 purchases and no sales on the market.

Most recently, on 19 June 2009, the filings show a transaction in Sonoma Pharmaceuticals, Inc. The most recent open-market purchase was published on 3 June 2009, 6,368 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.